As the market broadens beyond technology stocks, three Vanguard ETFs are positioned to benefit: the Healthcare ETF (VHT) is rallying on strong biotech and obesity drug prospects, the Value ETF (VTV) stands to gain as value stocks show renewed momentum after nearly two decades of underperformance, and the Small-Cap ETF (VB) is accelerating with attractive valuations and improving earnings estimates.
Axe note: As global markets move away from big tech, healthcare, value, and small-cap ETFs show fresh promise.